CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 488 enrolled
Drug / intervention
Manual Compression +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00345631
NCT00345631Phase 3Completed
CompareCT.gov

ECLIPSE Trial - Ensure's Vascular Closure Device Speeds Hemostasis Trial

Cordis US Corp.·interventional·Posted Jun 28, 2006·Updated Jun 1, 2012

In Brief

A Phase 3 clinical trial evaluating Manual Compression and Vascular Closure Device for Angioplasty, Transluminal, Percutaneous Coronary and 2 related conditions. Completed, enrolled 488 participants across 17 sites.

Detailed Summary

The purpose of this study is to determine whether the Ensure Medical Vascular Closure Device is more effective than standard manual compression at sealing the puncture made in the femoral artery following a cardiac or peripheral diagnostic or interventional procedure while maintaining the same level of safety.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAngioplasty, Transluminal, Percutaneous Coronary, Coronary Arteriosclerosis, Peripheral Arteriosclerosis
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 28, 2006
Enrollment StartFeb 1, 2007
Study CompletionSep 1, 2007
TodayJul 2, 2026
Posted 20.0 years ago

Interventions

Manual Compressionother

Manual compression

Vascular Closure Devicedevice

Investigational vascular closure device